guardant health将参加即将举行的投资者会议。 Guardant Health, Inc.(纳斯达克:GH)是一家领先的精准肿瘤医疗公司,今日宣布公司将参加以下投资者会议。 ● 古根海姆首届医疗创新大会 Businesswire11/01 19:00 GH将于11月06日盘后发布财报,一图速览分析师最新预测 富途资讯11/01 09:00 摩根士丹利维持Guardant Health...
Guardant Health, Inc. Common Stock (GH) After-Hours 最新更新数据 Oct 29, 2024 08:00 PM ET. 本页面恢复更新时间 Oct 30, 2024 04:00 PM ET. Latest After-Hours Trades -> View Latest After-Hours Trades -> 投资者可以进行盘前(美国东部时间上午 4:00 - 9:30) 和盘后(美国东部时间下午 4...
Get Guardant Health real-time stock quotes, news, price and financial information from Macroaxis. Analyze Guardant Health Stock Investing. Consider adding Guardant Stock to your portfolios
Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company, has announced the pricing of an upsized underwritten public offering of 12,500,000 shares of its common stock at a public offering price of US$28.00 per share, before deducting underwriting discounts an...
Current Price $8.57 NASDAQ: NVCR NovoCure Market Cap $2B Current Price $16.74 NASDAQ: INMD InMode Market Cap $1B Current Price $17.55 NASDAQ: TMDX TransMedics Group Market Cap $4B Current Price $125.17 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, ...
2024年8月7日盘后,美国肿瘤液态活检公司Guardant Health发布了2024Q2财报。财报显示,公司营收1.77亿美元,同比增长29.2%,环比增长5.2%。这也没毛病啊。哦,对,一定是亏损大幅提高了。2024Q2录得净亏损1.03亿美元,同比扩大41.0%。然而,事实上这是自2023Q4以来连续第三个季度的净亏损缩减,环比减少10.7%。看起来问题也...
Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company, has announced the pricing of an upsized underwritten public offering of 12,500,000 shares of its common stock at a public offering price of US$28.00 per share, before deducting underwriting discounts and commis...